je.st
news
Tag: license
UCC Provisions for Royalties and License Fees
2016-04-28 01:06:44| Expeditors Newsflash - Europe-Africa Edition
Expeditors Newsflash - Europe - MAIR Edition
Tags: license
fees
provisions
ucc
UCC Provisions for Royalties and License Fees
2016-04-27 10:00:00| Expeditors Newsflash - Americas Edition
Expeditors Newsflash - Americas Edition
Tags: license
fees
provisions
ucc
Optodot and LG Chem sign patent license agreement for boehmite ceramic-coated separators for Li-ion batteries
2016-04-19 10:56:13| Green Car Congress
Tags: sign
agreement
license
patent
BASF Obtains Battery Material License from CAMX Power LLC
2016-04-18 07:00:00| Coatings World Breaking News
Tags: power
material
license
llc
FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab) in Recurrent or Metastatic Head and Neck Cancer, and Grants Priority Review
2016-04-13 13:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558An Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: review
application
head
license
Sites : [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] next »